These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24014947)

  • 1. Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK(b) in intermediate β-thalassemia patient in Tabriz.
    Dolatkhah R; Esfahani A; Torabi SE; Kermani IA; Sanaat Z; Ziaei JE; Nikanfar A; Chavoshi SH; Ghoreishi Z; Kermani AA
    Asian J Transfus Sci; 2013 Jul; 7(2):149-50. PubMed ID: 24014947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three episodes of delayed hemolytic transfusion reactions due to multiple red cell antibodies, anti-Di, anti-Jk and anti-E.
    Yasuda H; Ohto H; Yamaguchi O; Sakuma S; Suzuki T; Mita M; Tsuneyama H; Uchikawa M
    Transfus Sci; 2000 Oct; 23(2):107-12. PubMed ID: 11035271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies.
    Guastafierro S; Sessa F; Cuomo C; Tirelli A
    Ann Hematol; 2004 May; 83(5):307-8. PubMed ID: 15064858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hemolytic transfusion reaction due to anti-Jk(a).
    Vucelic D; Savic N; Djordjevic R
    Acta Chir Iugosl; 2005; 52(3):111-5. PubMed ID: 16813007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
    Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impacts of DNA-based typing and provision of antigen-matched red blood cell units for chronically transfused patients with thalassemia.
    Watanaboonyongcharoen P; Onspun S; Rojnuckarin P
    Immunohematology; 2020 Dec; 36(4):137-145. PubMed ID: 33544619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β-thalassemia during perinatal transfusion.
    Wu Y; Ji Y; Dai B; Guo F; Wu Y; He Z; Mo C; Wu S; Hu Y
    Transfus Med; 2021 Feb; 31(1):24-29. PubMed ID: 33331032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A; Cash K; Uehlinger J
    Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd.
    Vaziri M; JavadzadehShahshahani H; Moghaddam M; Taghvaee N
    Iran J Ped Hematol Oncol; 2015; 5(2):93-9. PubMed ID: 26131348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A; Moreira G; Bordin JO
    Sao Paulo Med J; 1999 Jan; 117(1):38-9. PubMed ID: 10413970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience.
    Belsito A; Costa D; Signoriello S; Fiorito C; Tartaglione I; Casale M; Perrotta S; Magnussen K; Napoli C
    Transfus Apher Sci; 2019 Feb; 58(1):65-71. PubMed ID: 30591410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe delayed hemolytic transfusion reaction secondary to anti-At(a).
    Cash KL; Brown T; Sausais L; Uehlinger J; Reed LJ
    Transfusion; 1999 Aug; 39(8):834-7. PubMed ID: 10504118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jk
    El Alaoui K; Benghiat FS; Colard M
    J Hematol; 2022 Apr; 11(2):66-70. PubMed ID: 35573755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms responsible for delayed and immediate hemolytic transfusion reactions in a patient with anti-E + Jk(b)+ Di(b) and anti-HLA alloantibodies.
    Okamoto T; Hashimoto M; Samejima H; Mori A; Wakabayashi M; Takeda A; Nakamura H; Naruse H; Bouike Y; Araki N
    Immunopharmacol Immunotoxicol; 2004; 26(4):645-52. PubMed ID: 15658612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunization in autoimmune hemolytic anemia patient: The differential adsorption approach.
    Dara RC; Tiwari AK; Arora D; Mitra S; Acharya DP; Aggarwal G; Sharma J
    Asian J Transfus Sci; 2017; 11(1):53-57. PubMed ID: 28316442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhemolysis syndrome in anemia of chronic disease.
    Darabi K; Dzik S
    Transfusion; 2005 Dec; 45(12):1930-3. PubMed ID: 16371046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.